- Stage
- Became law
- Started in
- House
- Sponsors
- 77
- Latest action
- Jul 28, 2023
What it does
Creates the Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act. Provides that a manufacturer or wholesale drug distributor shall not engage in price gouging in the sale of an essential off-patent or generic drug. Provides that the Director of Healthcare and Family Services or Director of Central Management Services may notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the State’s Medical Assistance Program or a State health plan, respectively, that amounts to price gouging. Provides that whenever the Attorney General has reason to believe that a manufacturer or…
Where it stands
This bill passed and is now law.
Introduced (Done)
Committee (Done)
Floor (Done)
Law (Done)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
- Dave Koehler
- Nabeela Syed
- Aarón M. Ortíz
- Abdelnasser Rashid
- Adriane Johnson
- Ann Williams
- Anna Moeller
- Anne Stava
- Barbara Hernández
- Bob Morgan
- Bob Rita
- Camille Lilly
- Carol Ammons
- Celina Villanueva
- Chris Welch
- Cristina Castro
- Dan Didech
- Dave Vella
- Debbie Meyers-Martin
- Dee Avelar
- Doris Turner
- Edgar González, Jr.
- Emil Jones
- Gregg Johnson
- Harry Benton
- Hoan Huynh
- Jaime Andrade
- Janet Yang Rohr
- Javier Cervantes
- Jenn Ladisch-Douglass
- Jonathan Carroll
- Joyce Mason
- Justin Slaughter
- Kam Buckner
- Kelly Burke
- Kelly Cassidy
- Kevin Olickal
- Kimberly Lightford
- La Shawn Ford
- Lakesia Collins
- Laura Faver Dias
- Laura Murphy
- Lilian Jiménez
- Lindsey LaPointe
- Mark Walker
- Marty Moylan
- Mary Beth Canty
- Mary Edly-Allen
- Mary Flowers
- Matt Hanson
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
Once a bill is decided, the questions are about what is done with it in Illinois.